So-Young International Inc (SY)
0.8801
+0.08
(+10.05%)
USD |
NASDAQ |
Nov 14, 16:00
0.8801
0.00 (0.00%)
After-Hours: 17:55
So-Young International Gross Profit Margin (Quarterly): 61.94% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 61.94% |
| March 31, 2024 | 63.14% |
| December 31, 2023 | 64.76% |
| September 30, 2023 | 62.99% |
| June 30, 2023 | 63.51% |
| March 31, 2023 | 63.33% |
| December 31, 2022 | 72.87% |
| September 30, 2022 | 70.92% |
| June 30, 2022 | 66.20% |
| March 31, 2022 | 64.51% |
| December 31, 2021 | 71.73% |
| September 30, 2021 | 79.22% |
| June 30, 2021 | 86.99% |
| Date | Value |
|---|---|
| March 31, 2021 | 85.44% |
| December 31, 2020 | 85.02% |
| September 30, 2020 | 84.78% |
| June 30, 2020 | 84.54% |
| March 31, 2020 | 76.39% |
| December 31, 2019 | 83.66% |
| September 30, 2019 | 82.18% |
| June 30, 2019 | 82.52% |
| March 31, 2019 | 82.33% |
| December 31, 2018 | 82.72% |
| September 30, 2018 | 85.74% |
| June 30, 2018 | 86.11% |
| March 31, 2018 | 86.99% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
61.94%
Minimum
Jun 2024
86.99%
Maximum
Jun 2021
73.26%
Average
71.73%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 51.95% |
| Zai Lab Ltd | 64.94% |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 1.31% |
| Return on Assets | 1.05% |
| Return on Invested Capital | 1.30% |
| Profit Margin (Quarterly) | 4.65% |
| Operating Margin (Quarterly) | 1.65% |
| Return on Net Operating Assets | 2.87% |